Covance Becomes SCRS Global Impact Partner
The Society for Clinical Research Sites (SCRS) announced a two-year partnership with LabCorp.
The Society for Clinical Research Sites (SCRS) announced a two-year partnership with LabCorp. Under the agreement, Covance will participate as a Global Impact Partner (GIP), a relationship designed to facilitate dialogue between industry stakeholders and clinical research sites. As a GIP, Covance will participate on the SCRS Global Impact Board at an executive level, and work in tandem with SCRS’ Leadership Council in the development and execution of strategic initiatives for SCRS.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
How the NIMBLE Study Supported Adherence With Quarterly Dosing of CemdisiranSeptember 18th 2025
Everything to Know About FDA’s Push Towards Radical Transparency in 2025September 17th 2025
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
